Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02379819 · ClinicalTrials.gov registry record · NA
Hybrid L24 New Enrollment Post Approval Study
A NA study, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT02379819 is a NA study that has completed, run by Cochlear. The registered enrollment target is 52 participants.
The verdict
NCT02379819, a NA study, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
This study evaluates the long term safety and effectiveness of the Nucleus Hybrid L24 Implant in a group of newly implanted adults.
Interventions
- DEVICE Nucleus Hybrid L24 Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2015-02 |
| Est. Completion | 2022-04-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02379819
The ClinicalTrials.gov registry entry for NCT02379819 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nucleus Hybrid L24 Implant is the first listed.
NCT02379819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02379819 about?
NCT02379819 is a clinical study titled "Hybrid L24 New Enrollment Post Approval Study". This study evaluates the long term safety and effectiveness of the Nucleus Hybrid L24 Implant in a group of newly implanted adults.
What is the current status of trial NCT02379819?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2015-02. Estimated completion is 2022-04-14.
What interventions are being tested in trial NCT02379819?
The interventions under investigation include: Nucleus Hybrid L24 Implant (DEVICE).
Who is sponsoring clinical trial NCT02379819?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.